NCT04773028View on ClinicalTrials.gov

The Role of Matrix Metalloproteinase 2 and 9 Enzymes in Developing Chronic Thromboembolic Pulmonary Hypertension

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

May 4, 2021

Study Completion Date

May 4, 2021

Conditions
Chronic Thromboembolic Pulmonary Hypertension
Interventions
OTHER

matrix metalloproteinase enzymes 2 and 9

concentration of matrix metalloproteinase 2 and 9 enzymes

Trial Locations (1)

34800

Kartal Kosuyolu High Speciality Training and Research Hospital, Istanbul

All Listed Sponsors
lead

AHMET ZENGIN

OTHER_GOV

NCT04773028 - The Role of Matrix Metalloproteinase 2 and 9 Enzymes in Developing Chronic Thromboembolic Pulmonary Hypertension | Biotech Hunter | Biotech Hunter